Dermatologicals in Norway

Dermatologicals in Norway

Dermatologicals is set to see current value growth in Norway in 2024. The third largest OTC consumer health category after cough, cold and allergy (hay fever) remedies and analgesics, dermatologicals has displayed a strong performance since the COVID-19 crisis (similar to many other categories). As a result, 2024 is expected to be a return to longstanding trends and more stable growth. There is a strong demand for dermatologicals, due to players’ marketing activity and Norwegians increasingly wa...

Euromonitor International's Dermatologicals in Norway report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.